GEN Edge - Latest

Latest

All

Artificial Intelligence

CZI to Build Massive GPU Cluster for Decoding Biology with AI

Drug Discovery

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

Drug Discovery

After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?

Bioprocessing

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger

Drug Discovery

StockWatch: Abcam Founder Opposes $5.7B Danaher Acquisition

Drug Discovery

Can CRISPR Crack the Code to Treating HIV Infections?

Artificial Intelligence

Generate:Biomedicines Raises Largest Biotech Series C of 2023

Artificial Intelligence

Chemify to Dream Up and Deliver Drugs for Dewpoint Therapeutics

Drug Discovery

Lights, Camera: Actio Biosciences Launches to Bridge Common and Rare Disease Treatments

Artificial Intelligence

Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale

Artificial Intelligence

Superluminal Medicines Launches to Drug Protein Conformations in a Flash

OMICs

StockWatch: Investors, Analysts Debate Background of New Illumina CEO

OMICs

StockWatch: Despite 3-Week Decline, PacBio Stock Doubles in a Year

Close to the Edge

Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning

GEN Edge

Lessons from the Minimal Cell

Artificial Intelligence

Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery

OMICs

StockWatch: Illumina Results Leave Investors, Analysts Anxious

Drug Discovery

StockWatch: Regeneron’s All Ears for Hearing Loss Drug Developer

Artificial Intelligence

Ordaōs Uses AI to Generate Therapeutic Mini-Proteins

Genome Editing

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger

Drug Discovery

Solu Therapeutics Launches with $31 Million to Unlock Cell-Surface Targets

Drug Discovery

StockWatch: Apellis Shares Nosedive 73% on Safety Concerns

Summits

The State of Biotech 2023

Drug Discovery

StockWatch: Layoffs Extend Biogen’s Stock Skid

Drug Discovery

Trier Bryant Pairs 82VS with Alloy to Create Asset-Centric Companies

OMICs

StockWatch: Quantum-Si Surges 47% as ARK Raises Its Stake

Artificial Intelligence

StockWatch: After $50M from Nvidia, Investors Bullish on Recursion

Artificial Intelligence

Boston Calling: Genomenon Acquires Boston Genetics for Rapid Human Genome Curation

Artificial Intelligence

Verily Rolling Along: Google’s Life-Sci Sister Doubles Down on AI

Infectious Diseases

AGT Spins Out Addimmune, Focusing on Functional HIV Cure